With 2.96 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.61 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.238 whereas the lowest price it dropped to was $0.2302. The 52-week range on EPIX shows that it touched its highest point at $7.88 and its lowest point at $0.22 during that stretch. It currently has a 1-year price target of $2.00. With its current market cap of 10.96 million, EPIX has annualized dividend of $1.69 while the current yield stands at 730.14%. EPIX paid its most recent dividend on 1756080000, while the ex-dividend date for that was 1756080000. Beta for the stock currently stands at 1.57.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EPIX was down-trending over the past week, with a drop of -5.70%, but this was down by -87.75% over a month. Three-month performance dropped to -86.46% while six-month performance fell -86.30%. The stock lost -87.06% in the past year, while it has lost -95.86% so far this year.
Float and Shares Shorts:
At present, 47.31 million EPIX shares are outstanding with a float of 44.48 million shares on hand for trading. On 2025-08-15, short shares totaled 0.96 million, which was 202.99999 higher than short shares on 1752537600. In addition to Dr. David Ross Parkinson M.D. as the firm’s President, CEO & Director, Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA serves as its Chief Financial Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, EPIX reported revenue of $0.0 and operating income of -$4996152.0. The EBITDA in the recently reported quarter was -$5972648.0 and diluted EPS was -$0.09.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.63926 being high and -$0.72643 being low. For EPIX, this leads to a yearly average estimate of -$0.678. The surprise factor in the prior quarter was -$0.25.
